natgillin/translations-raw huggingface dataset:
She has been awarded with Russian State order ‘For duties to the motherland’ — II degree in 2014 and with the order ‘For loyalty to duty’ by the ‘authorities’ of ‘Republic of Crimea’ in 2015.
U 2014. odlikovana je ruskim državnim odličjem drugog reda „za dužnost prema domovini”, a u 2015. „tijela” „Republike Krima” dodijelila su joj odlikovanje za „odanu dužnost”.
Address: Donetsk.
Adresa: Donetsk.
(a.k.a. CONCERN ALMAZ-ANTEY; ALMAZ-ANTEY CORP; a.k.a. ALMAZ-ANTEY DEFENSE CORPORATION; a.k.a. ALMAZ-ANTEY JSC; Концерн ВКО ‘Алмаз — Антей;
(također poznato kao CONCERN ALMAZ-ANTEY; ALMAZ-ANTEY CORP; također poznato kao ALMAZ-ANTEY DEFENSE CORPORATION; također poznato kao ALMAZ-ANTEY JSC; Концерн ВКО „Алмаз – Антей;
Council Decision (EU) 2017/446
Odluka Vijeća (EU) 2017/446
on the conclusion on behalf of the European Union of the Protocol (2015) amending the Annex to the Agreement on Trade in Civil Aircraft
o sklapanju, u ime Europske unije, Protokola (2015.) o izmjeni Priloga Sporazumu o trgovini civilnim zrakoplovima
Having regard to the Treaty on the Functioning of the European Union, and in particular first subparagraph of Article 207(4), in conjunction with Article 218(6)(a) thereof,
uzimajući u obzir Ugovor o funkcioniranju Europske unije, a posebno njegov članak 207. stavak 4. prvi podstavak u vezi s člankom 218. stavkom 6. točkom (a),
By means of Decision 80/271/EEC [2], the Council approved the conclusion of the GATT Agreement on Trade in Civil Aircraft (the Agreement).
Vijeće je Odlukom 80/271/EEZ [2] odobrilo sklapanje Sporazuma GATT-a o trgovini civilnim zrakoplovima („Sporazum”).
Signatories to the Agreement, through their representatives, agreed to open the Protocol (2015) Amending the Annex to the Agreement on Trade in Civil Aircraft (the Protocol) for acceptance in Geneva on 5 November 2015, transposing into the Annex to the Agreement the changes introduced in the 2007 version of the Harmonized Commodity Description and Coding System.
Potpisnici Sporazuma suglasili su se, putem svojih predstavnika, 5. studenoga 2015. u Ženevi da se za prihvat otvori Protokol (2015.) o izmjeni Priloga Sporazumu o trgovini civilnim zrakoplovima („Protokol”), kojim se u Prilog Sporazumu prenose promjene uvedene verzijom iz 2007. Harmoniziranog sustava nazivlja i brojčanog označivanja robe.
The Protocol (2015) amending the Annex to the Agreement on Trade in Civil Aircraft is hereby approved on behalf of the Union.
Protokol (2015.) o izmjeni Priloga Sporazumu o trgovini civilnim zrakoplovima odobrava se u ime Unije.
The President of the Council shall designate the person(s) empowered to deposit, on behalf of the Union, the instrument of acceptance in order to express the consent of the Union to be bound by the Protocol [3].Article 3
Predsjednik Vijeća određuje jednu ili više osoba ovlaštenih za polaganje, u ime Unije, isprave o prihvatu kako bi se izrazila suglasnost Unije da bude obvezana Protokolom [3].Članak 3.
Consent of 15 February 2017 (not yet published in the Official Journal).
Suglasnost od 15. veljače 2017. (još nije objavljena u Službenom listu).
Council Decision 80/271/EEC of 10 December 1979 concerning the conclusion of the Multilateral Agreements resulting from the 1973 to 1979 trade negotiations (OJ L 71, 17.3.1980, p. 1).
Odluka Vijeća 80/271/EEZ od 10. prosinca 1979. o sklapanju multilateralnih sporazuma slijedom trgovinskih pregovora od 1973. do 1979. (SL L 71, 17.3.1980., str. 1.).
Council Decision (EU) 2017/449
Odluka Vijeća (EU) 2017/449
on the position to be adopted, on behalf of the European Union, in the 60th session of the Commission on Narcotic Drugs on the scheduling of substances under the Single Convention on Narcotic Drugs of 1961, as amended by the 1972 Protocol, and the Convention on Psychotropic Substances of 1971
o stajalištu koje treba zauzeti u ime Europske unije na 60. sjednici Komisije za opojne droge o uvrštavanju tvari u tablice u Jedinstvenoj konvenciji o opojnim drogama iz 1961., kako je izmijenjena Protokolom iz 1972., i Konvenciji o psihotropnim tvarima iz 1971.
Having regard to the Treaty on the Functioning of the European Union, and in particular Article 83(1) in conjunction with Article 218(9) thereof,
uzimajući u obzir Ugovor o funkcioniranju Europske unije, a posebno njegov članak 83. stavak 1. u vezi s člankom 218. stavkom 9.,
The United Nations (UN) Single Convention on Narcotic Drugs of 1961, as amended by the 1972 Protocol, (the ‘Convention on Narcotic Drugs’) entered into force on 8 August 1975.
Jedinstvena konvencija Ujedinjenih naroda (UN) o opojnim drogama iz 1961., kako je izmijenjena Protokolom iz 1972., („Konvencija o opojnim drogama”) stupila je na snagu 8. kolovoza 1975.
Pursuant to Article 3 of the Convention on Narcotic Drugs, the Commission on Narcotic Drugs may decide to add substances to the Schedules of that Convention.
Na temelju članka 3. Konvencije o opojnim drogama Komisija za opojne droge može odlučiti dodati tvari u tablice u toj konvenciji.
It can make changes to the Schedules only in accordance with the recommendations of the World Health Organisation (WHO), but it can also decide not to make the changes recommended by the WHO.
Tablice može mijenjati samo u skladu s preporukama Svjetske zdravstvene organizacije (WHO), no može odlučiti i da neće unijeti promjene koje preporuči WHO.
The UN Convention on Psychotropic Substances of 1971 (the ‘Convention on Psychotropic Substances’) entered into force on 16 August 1976.
Konvencija UN-a o psihotropnim tvarima iz 1971. („Konvencija o psihotropnim tvarima”) stupila je na snagu 16. kolovoza 1976.
Pursuant to Article 2 of the Convention on Psychotropic Substances, the Commission on Narcotic Drugs may decide to add substances to the Schedules of that Convention, or to remove them, on the basis of the recommendations of the WHO.
Na temelju članka 2. Konvencije o psihotropnim tvarima Komisija za opojne droge može, na temelju preporuka WHO-a, odlučiti dodati tvari u tablice u toj konvenciji ili ih brisati iz njih.
It has broad discretionary powers to take into account economic, social, legal, administrative and other factors, but may not act arbitrarily.
Ona ima široke diskrecijske ovlasti uzimati u obzir gospodarske, društvene, pravne, administrativne i druge čimbenike, no ne može proizvoljno djelovati.
Changes to the Schedules of both Conventions have direct repercussions on the scope of application of Union law in the area of drug control.
Promjene u tablicama obiju konvencija imaju izravne posljedice na područje primjene prava Unije u području kontrole droga.
Council Framework Decision 2004/757/JHA [1] applies to substances listed in the Schedules to the Convention on Narcotic Drugs and the Convention on Psychotropic Substances.
Okvirna odluka Vijeća 2004/757/PUP [1] primjenjuje se na tvari navedene u tablicama priloženima Konvenciji o opojnim drogama i Konvenciji o psihotropnim tvarima.
Council Decision 2005/387/JHA [2] does not apply to substances listed in the Schedules to the Convention on Narcotic Drugs or to the Convention on Psychotropic Substances.
Odluka Vijeća 2005/387/PUP [2] ne primjenjuje se na tvari navedene u tablicama priloženima Konvenciji o opojnim drogama i Konvenciji o psihotropnim tvarima.
Thus, any change to the Schedules annexed to those Conventions is directly incorporated into common Union rules.
Stoga se svaka promjena tablica priloženih tim konvencijama izravno uključuje u zajednička pravila Unije.
The Commission on Narcotic Drugs should decide, during its 60th session on 13 to 17 March 2017 in Vienna, on the addition of 10 new substances to the Schedules of the Conventions.
Komisija za opojne droge trebala bi na svojoj 60. sjednici od 13. do 17. ožujka 2017. u Beču odlučiti o dodavanju deset novih tvari u tablice u konvencijama.
The Union is not a party to the relevant UN conventions.
Unija nije stranka relevantnih konvencija UN-a.
It has an observer status in the Commission on Narcotic Drugs, where currently 12 Member States are members with the right to vote.
Ima status promatrača u Komisiji za opojne droge, u kojoj je trenutačno 12 država članica s pravom glasa.
It is therefore necessary that the Member States express the position of the Union on the scheduling of substances under the Convention on Narcotic Drugs and the Convention on Psychotropic Substances.
Stoga je potrebno da države članice izraze stajalište Unije o uvrštavanju tvari u tablice u Konvenciji o opojnim drogama i Konvenciji o psihotropnim tvarima.
The position to be adopted on the Union's behalf at the next session of the Commission on Narcotic Drugs only concerns the scheduling of substances under the Conventions.
Stajalište koje treba zauzeti u ime Unije na sljedećoj sjednici Komisije za opojne droge odnosi se samo na uvrštavanje tvari u tablice u konvencijama.
Matters other than the scheduling of substances are not the object of the present decision and will be dealt by the Member States through coordination in the margins of the session of the Commission on Narcotic Drugs as appropriate.
Pitanja koja se ne odnose na uvrštavanje tvari u tablice nisu predmet ove Odluke i države članice njima će se prema potrebi baviti koordinacijom na marginama sjednice Komisije za opojne droge.
This Decision is without prejudice to the delimitation of competences between the Union and the Member States on other matters in relation to the Conventions.
Ovom Odlukom ne dovodi se u pitanje razgraničenje nadležnosti između Unije i država članica u pogledu drugih pitanja u vezi s konvencijama.
The WHO recommended on 2 December 2016 to the Secretary-General of the UN to add two new substances to Schedule I of the Convention on Narcotic Drugs, and eight new substances to Schedule II of the Convention on Psychotropic Substances.
WHO je 2. prosinca 2016. preporučio glavnom tajniku UN-a da doda dvije nove tvari u Tablicu I. Konvencije o opojnim drogama i osam novih tvari u Tablicu II. Konvencije o psihotropnim tvarima.
According to the assessment of the WHO Expert Committee on Drug Dependence (the Expert Committee), U-47700 (3,4-dichloro-N-(2-dimethylamino-cyclohexyl)-N-methyl-benzamide) is a compound liable to similar abuse as and with similar ill-effects to those of controlled opioids such as morphine and AH-7921, that are included in Schedule I of the Convention on Narcotic Drugs.
Kako je procijenio Stručni odbor WHO-a za ovisnosti o drogama („Stručni odbor”), tvar U-47700 (3,4-dikloro-N-(2-dimetilamino-cikloheksil)-N-metilbenzamid) može se zloupotrebljavati i djeluje štetno slično kontroliranim opioidima, kao što su morfij i AH-7921, koji su uvršteni u Tablicu I. Konvencije o opojnim drogama.
It has no recorded therapeutic use, and its use has resulted in fatalities.
Nema zabilježenu terapijsku primjenu, a njegovo je uzimanje rezultiralo smrtnim slučajevima.
There is sufficient evidence that it is being or is likely to be abused, and may become a public health and social problem that warrants placing the substance under international control.
Postoji dovoljno dokaza da se zloupotrebljava ili da će se vjerojatno zloupotrebljavati te da može postati javnozdravstveni i društveni problem što opravdava njezino stavljanje pod međunarodnu kontrolu.
Consequently, the WHO recommends that U-47700 be placed in Schedule I of the Convention on Narcotic Drugs.
Zbog toga WHO preporučuje da se tvar U-47700 uvrsti u Tablicu I. Konvencije o opojnim drogama.
U-47700 is monitored by the European Monitoring Centre for Drugs and Drug Addiction as a new psychoactive substance under the terms of Decision 2005/387/JHA.
Europski centar za praćenje droga i ovisnosti o drogama prati U-47700 kao novu psihoaktivnu tvar u skladu s Odlukom 2005/387/PUP.
U-47700 has been detected in 14 Member States.
Tvar U-47700 otkrivena je u 14 država članica.
It has been sold openly on the market.
Otvoreno se prodaje na tržištu.
It has been associated with serious adverse events, including deaths, and has been the subject of a public health-related alert issued to the Union Early Warning System.
Dovedena je u vezu s događajima s teškim posljedicama, uključujući i smrtne slučajeve, te je za nju izdano javnozdravstveno upozorenje u okviru sustava ranog upozoravanja u Uniji.
Therefore, the Member States should take the position to add U-47700 to Schedule I of the Convention on Narcotic Drugs.
Stoga bi države članice trebale zauzeti stajalište da se U-47700 doda u Tablicu I. Konvencije o opojnim drogama.
According to the assessment of the Expert Committee, butyrfentanyl (N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]butanamide) is a compound liable to similar abuse as and with similar ill-effects to those of controlled opioids, such as morphine and fentanyl, that are included in Schedule I of the Convention on Narcotic Drugs.
Kako je procijenio Stručni odbor, butirfentanil (N-fenil-N-[1-(2-feniletil)-4-piperidinil]butanamid) može se zloupotrebljavati i djeluje štetno slično kontroliranim opioidima, kao što su morfij i fentanil, koji su uvršteni u Tablicu I. Konvencije o opojnim drogama.
It can also be converted into fentanyl.
Može ga se i pretvoriti u fentanil.
There is sufficient evidence that it is being or is likely to be abused, and may constitute a public health and social problem that warrants placing the substance under international control.
Postoji dovoljno dokaza da se zloupotrebljava ili da će se vjerojatno zloupotrebljavati te da može biti javnozdravstveni i društveni problem što opravdava njegovo stavljanje pod međunarodnu kontrolu.
Thus, the WHO recommends that butyrfentanyl be placed in Schedule I of the Convention on Narcotic Drugs.
Zbog toga WHO preporučuje da se butirfentanil uvrsti u Tablicu I. Konvencije.
Butyrfentanyl is monitored by the European Monitoring Centre for Drugs and Drug Addiction as a new psychoactive substance under the terms of Decision 2005/387/JHA.
Europski centar za praćenje droga i ovisnosti o drogama prati butirfentanil kao novu psihoaktivnu tvar u skladu s Odlukom 2005/387/PUP.
Butyrfentanyl has been detected in six Member States.
Butirfentanil je otkriven u šest država članica.
It has been associated with serious adverse events, including the case of at least one death in which it was detected and has been the subject of a public-health-related alert issued to the Union Early Warning System.
Doveden je u vezu s događajima s teškim posljedicama, otkriven je u najmanje jednom smrtnom slučaju, te je za njega izdano javnozdravstveno upozorenje u okviru sustava ranog upozoravanja u Uniji.
Therefore, the Member States should take the position to add butyrfentanyl to Schedule I of the Convention on Narcotic Drugs.
Stoga bi države članice trebale zauzeti stajalište da se butirfentanil doda u Tablicu I. Konvencije o opojnim drogama.
According to the assessment of the Expert Committee, the degree of risk to public health and society associated with the abuse of 4-methylethcathinone or 4-MEC (2-(ethylamino)-1-(4-methylphenyl) propan-1-one) is substantial.
Kako je procijenio Stručni odbor, zloupotreba 4-metiletkatinona (4-MEC) (2-(etilamino)-1-(4-metilfenil) propan-1-on) povezana je sa znatnim stupnjem rizika za javno zdravlje i društvo.
EC has no recorded therapeutic use.
Terapijska korist tvari 4-MEC nije zabilježena.
The Expert Committee recognises that 4-MEC has similar abuse potential to and similar ill-effects to those of substances in Schedule II of the Convention on Psychotropic Substances.
Stručni odbor utvrdio je da 4-MEC ima potencijal za zloupotrebu i štetno djelovanje slično tvarima uvrštenima u Tablicu II. Konvencije o psihotropnim tvarima.
The Expert Committee considers that there is sufficient evidence that 4-MEC is being or is likely to be abused, and therefore constitutes a public health and social problem that warrants placing the substance under international control.
Stručni odbor smatra da ima dovoljno dokaza da se 4-MEC zloupotrebljava ili da će se vjerojatno zloupotrebljavati te stoga predstavlja javnozdravstveni i društveni problem što opravdava njegovo stavljanje pod međunarodnu kontrolu.
Thus, the WHO recommends that 4-MEC be placed in Schedule II under the Convention on Psychotropic Substances.
Zbog toga WHO preporučuje da se 4-MEC uvrsti u Tablicu II. Konvencije o psihotropnim tvarima.
EC is monitored by the European Monitoring Centre for Drugs and Drug Addiction as a new psychoactive substance under the terms of Decision 2005/387/JHA.
Europski centar za praćenje droga i ovisnosti o drogama prati 4-MEC kao novu psihoaktivnu tvar u skladu s Odlukom 2005/387/PUP.
EC has been detected in 19 Member States.
EC otkriven je u 19 država članica.
It has been associated with small number of serious adverse events, including deaths.
Doveden je u vezu s malim brojem događaja s teškim posljedicama, među kojima su i smrtni slučajevi.
Therefore, the Member States should take the position to add 4-MEC to Schedule II of the Convention on Psychotropic Substances.
Stoga bi države članice trebale zauzeti stajalište da se 4-MEC doda u Tablicu II. Konvencije o psihotropnim tvarima.
According to the assessment of the Expert Committee, the degree of risk to public health and society associated with the abuse of ethylone (1-(2H-1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one) is substantial.
Kako je procijenio Stručni odbor, zloupotreba etilona (1-(2H-1,3-benzodioksol-5-il)-2-(etilamino)propan-1-on) povezana je sa znatnim stupnjem rizika za javno zdravlje i društvo.
Ethylone has no recorded therapeutic use.
Terapijska korist etilona nije zabilježena.
The Expert Committee recognises that ethylone (1-(2H-1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one) has similar abuse potential to and similar ill-effects to those of substances in Schedule II of the Convention on Psychotropic Substances.
Stručni odbor utvrdio je da etilon (1-(2H-1,3-benzodioksol-5-il)-2-(etilamino)propan-1-on) ima potencijal za zloupotrebu i štetno djelovanje slično tvarima uvrštenim u Tablicu II. Konvencije o psihotropnim tvarima.
The Expert Committee considers that there is sufficient evidence that ethylone is being or is likely to be abused, and therefore constitutes a public health and social problem that warrants the placing of the substance under international control.
Stručni odbor smatra da ima dovoljno dokaza da se etilon zloupotrebljava ili da će se vjerojatno zloupotrebljavati te stoga predstavlja javnozdravstveni i društveni problem što opravdava njegovo stavljanje pod međunarodnu kontrolu.
Thus, the WHO recommends that ethylone be placed in Schedule II under the Convention on Psychotropic Substances.
Zbog toga WHO preporučuje da se etilon uvrsti u Tablicu II. Konvencije o psihotropnim tvarima.
Ethylone is monitored by the European Monitoring Centre for Drugs and Drug Addiction as a new psychoactive substance under the terms of Decision 2005/387/JHA.
Europski centar za praćenje droga i ovisnosti o drogama prati etilon kao novu psihoaktivnu tvar u skladu s Odlukom 2005/387/PUP.
Ethylone has been detected in 19 Member States.
Etilon je otkriven u 19 država članica.
Therefore, the Member States should take the position to add ethylone to Schedule II of the Convention on Psychotropic Substances.
Stoga bi države članice trebale zauzeti stajalište da se etilon doda u Tablicu II. Konvencije o psihotropnim tvarima.
According to the Expert Committee, the degree of risk to public health and society associated with the abuse of pentedrone or α-methylaminovalerophenone (2-(methylamino)-1-phenylpentan-1-one), is substantial.
Kako je procijenio Stručni odbor, zloupotreba pentedrona ili alfa-metilaminovalerofenona (2-(metilamino)-1-fenilpentan-1-on) povezana je sa znatnim stupnjem rizika za javno zdravlje i društvo.
Pentedrone has no recorded therapeutic use.
Terapijska korist pentedrona nije zabilježena.
Thus, the WHO recommends that pentedrone be placed in Schedule II under the Convention on Psychotropic Substances.
Zbog toga WHO preporučuje da se pentedron uvrsti u Tablicu II. Konvencije o psihotropnim tvarima.
Pentedrone is monitored by the European Monitoring Centre for Drugs and Drug Addiction as a new psychoactive substance under the terms of Decision 2005/387/JHA.
Europski centar za praćenje droga i ovisnosti o drogama prati pentedron kao novu psihoaktivnu tvar u skladu s Odlukom 2005/387/PUP.
Pentedrone has been detected in 18 Member States.
Pentedron je otkriven u 18 država članica.
It has been associated with a small number of serious adverse events, including deaths.
Doveden je u vezu s malim brojem događaja s teškim posljedicama, među kojima su i smrtni slučajevi.
Therefore, the Member States should take the position to add pentedrone to Schedule II of the Convention on Psychotropic Substances.
Stoga bi države članice trebale zauzeti stajalište da se pentedron doda u Tablicu II. Konvencije o psihotropnim tvarima.
According to the Expert Committee, the degree of risk to public health and society associated with the abuse of ethylphenidate or EPH (ethyl phenyl(piperidin-2-yl)acetate) is substantial.
Kako je procijenio Stručni odbor, zloupotreba etilfenidata (EPH) (etil fenil(piperidin-2-il)acetat) povezana je sa znatnim stupnjem rizika za javno zdravlje i društvo.
Ethylphenidate has no recorded therapeutic use.
Terapijska korist etilfenidata nije zabilježena.
The Expert Committee recognises that ethylphenidate has similar abuse potential to and similar ill-effects to those of substances in Schedule II of the Convention on Psychotropic Substances.
Stručni odbor utvrdio je da etilfenidat ima potencijal za zloupotrebu i štetno djelovanje slično tvarima uvrštenim u Tablicu II. Konvencije o psihotropnim tvarima.
The Expert Committee considers that there is sufficient evidence that ethylphenidate is being or is likely to be abused, and therefore constitutes a public health and social problem that warrants placing the substance under international control.
Stručni odbor smatra da ima dovoljno dokaza da se etilfenidat zloupotrebljava ili da će se vjerojatno zloupotrebljavati te stoga predstavlja javnozdravstveni i društveni problem što opravdava njegovo stavljanje pod međunarodnu kontrolu.
Thus, the WHO recommends that ethylphenidate be placed in Schedule II under the Convention on Psychotropic Substances.
Zbog toga WHO preporučuje da se etilfenidat uvrsti u Tablicu II. Konvencije o psihotropnim tvarima.
Ethylphenidate is monitored by the European Monitoring Centre for Drugs and Drug Addiction as a new psychoactive substance under the terms of Decision 2005/387/JHA.
Europski centar za praćenje droga i ovisnosti o drogama prati etilfenidat kao novu psihoaktivnu tvar u skladu s Odlukom 2005/387/PUP.
Ethylphenidate has been detected in 13 Member States.
Etilfenidat je otkriven u 13 država članica.
It has been associated with serious adverse events, including soft tissue infections and deaths.
Doveden je u vezu s događajima s teškim posljedicama, među kojima su infekcije mekog tkiva i smrtni slučajevi.
Soft tissue infections related to injection have been the subject of a public-health-related alert issued to the Union Early Warning System.
Za infekcije mekog tkiva zbog intravenoznog uzimanja izdano je javnozdravstveno upozorenje u okviru sustava ranog upozoravanja u Uniji.
Therefore, the Member States should take the position to add ethylphenidate to Schedule II of the Convention on Psychotropic Substances.
Stoga bi države članice trebale zauzeti stajalište da se etilfenidat doda u Tablicu II. Konvencije o psihotropnim tvarima.
According to the Expert Committee, the degree of risk to public health and society associated with the abuse of MPA or methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-amine) is substantial.
Kako je procijenio Stručni odbor, zloupotreba metiopropamina (MPA) (N-metil-1-(tiofen-2-il)propan-2-amin) povezana je sa znatnim stupnjem rizika za javno zdravlje i društvo.
MPA has no recorded therapeutic use.
Terapijska korist metiopropamina nije zabilježena.
The Expert Committee recognises that MPA has similar abuse potential to and similar ill-effects to those of substances in Schedule II of the Convention on Psychotropic Substances.
Stručni odbor utvrdio je da metiopropamin ima potencijal za zloupotrebu i štetno djelovanje slično tvarima uvrštenim u Tablicu II. Konvencije o psihotropnim tvarima.